Diagnosing Inflammatory bowel disease using noninvasive applications of volatile organic compounds: a systematic review
- PMID: 31657950
- DOI: 10.1080/17474124.2019.1685873
Diagnosing Inflammatory bowel disease using noninvasive applications of volatile organic compounds: a systematic review
Abstract
Introduction: Inflammatory bowel disease (IBD) is a common disease with significant morbidity. Noninvasive diagnostic techniques are lacking in IBD. Currently, fecal calprotectin is a sensitive marker of gut inflammation however is not specific to Crohn's disease (CD) or ulcerative colitis (UC) alone. Volatile organic compounds (VOCs) were shown to have potential in IBD diagnosis.Areas covered: This systematic review aimed to examine the next-generation diagnosis of IBD in adults and children using VOCs. An in-depth literature-based search of current clinical studies of VOCs in the diagnosis of IBD was undertaken. Accuracy of IBD detection varied according to the technologies applied. Breath VOCs studies were pooled giving an overall sensitivity of 85% (95%CI: 79-89%) and specificity of 79% (95%CI 73-84%) whilst pooled fecal VOCs studies revealed a sensitivity of 87% (95%CI 77-93%) and specificity of 91% (95%CI 82-96%). Studies were limited by the variance of techniques applied in VOCs detection and the absence of well-designed longitudinal studies.Expert opinion: VOCs can be consistently and effectively detected in urine, breath, and stool in IBD patients. The sensitivity of breath VOCs in detecting IBD was comparable to feces. However, optimal VOCs detection methodology and biological sampling still need to be standardized..
Keywords: Crohn’s disease; Inflammatory bowel disease; diagnosis; ulcerative colitis; volatile organic compounds.
Similar articles
-
Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.J Crohns Colitis. 2015 Sep;9(9):731-7. doi: 10.1093/ecco-jcc/jjv102. Epub 2015 Jun 12. J Crohns Colitis. 2015. PMID: 26071410
-
Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD).Dig Liver Dis. 2016 Feb;48(2):148-53. doi: 10.1016/j.dld.2015.10.013. Epub 2015 Nov 22. Dig Liver Dis. 2016. PMID: 26682719
-
Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.J Gastrointestin Liver Dis. 2018 Sep;27(3):299-306. doi: 10.15403/jgld.2014.1121.273.pti. J Gastrointestin Liver Dis. 2018. PMID: 30240474
-
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.Am J Gastroenterol. 2015 Jun;110(6):802-19; quiz 820. doi: 10.1038/ajg.2015.120. Epub 2015 May 12. Am J Gastroenterol. 2015. PMID: 25964225 Review.
-
The role of fecal biomarkers in individuals with inflammatory bowel disease.Expert Rev Mol Diagn. 2024 Jun;24(6):497-508. doi: 10.1080/14737159.2024.2375224. Epub 2024 Jul 12. Expert Rev Mol Diagn. 2024. PMID: 38995110 Review.
Cited by
-
Are Volatile Organic Compounds Accurate Markers in the Assessment of Colorectal Cancer and Inflammatory Bowel Diseases? A Review.Cancers (Basel). 2021 May 13;13(10):2361. doi: 10.3390/cancers13102361. Cancers (Basel). 2021. PMID: 34068419 Free PMC article. Review.
-
The breath volatilome is shaped by the gut microbiota.medRxiv [Preprint]. 2024 Aug 8:2024.08.02.24311413. doi: 10.1101/2024.08.02.24311413. medRxiv. 2024. PMID: 39132488 Free PMC article. Preprint.
-
Volatolomics in healthcare and its advanced detection technology.Nano Res. 2022;15(9):8185-8213. doi: 10.1007/s12274-022-4459-3. Epub 2022 Jun 29. Nano Res. 2022. PMID: 35789633 Free PMC article. Review.
-
Delayed diagnosis in inflammatory bowel disease: Time to consider solutions.World J Gastroenterol. 2024 Sep 21;30(35):3954-3958. doi: 10.3748/wjg.v30.i35.3954. World J Gastroenterol. 2024. PMID: 39351057 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical